GLUE
#2043
Monte Rosa Therapeutics, Inc. - Common Stock
21.9 8 USD
-0.05%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.60%
Monthly Change
+18.24%
6 month change
-8.53%
Year Change
+94.51%
Previous Close
23.0 4
Open
21.9 8
Low
21.9 8
High
21.9 8
Volume
91
Financials
- Market Capitalization 1.86 B
- Employee 161
- Founded 2019
- CEO N/A
- Website www.monterosatx.com
- Headquarter Delaware, United States
- FIGI BBG00X2VGZQ3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-33.72
Price to sales ratio
10.53
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2014 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 39.51 USD | +2.46% | +5.36% | +33.71% | +107.95% | 1.92 B USD | ||
| 2028 |  NBTX Nanobiotix S.A. - ADSs | 39.15 USD | -2.30% | -3.69% | +5.24% | +629.05% | 1.90 B USD | ||
| 2044 |  BCAX Bicara Therapeutics Inc. - Common Stock | 28.15 USD | -2.63% | -4.41% | +28.36% | +94.94% | 1.85 B USD | ||
| 2051 |  PGEN Precigen, Inc. - Common Stock | 5.17 USD | -2.82% | -8.17% | +12.39% | +163.78% | 1.84 B USD |
Frequently asked questions about Monte Rosa Therapeutics, Inc. - Common Stock
What is the Monte Rosa Therapeutics, Inc. - Common Stock stock price today?
The current price of Monte Rosa Therapeutics, Inc. - Common Stock (GLUE) is 21.98. Over the past 24 hours, the stock has changed by -4.60%. Follow the GLUE chart for real-time price dynamics.
What is the stock ticker of Monte Rosa Therapeutics, Inc. - Common Stock?
Monte Rosa Therapeutics, Inc. - Common Stock trades under the ticker GLUE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Monte Rosa Therapeutics, Inc. - Common Stock stock going up?
GLUE has changed by -6.43% over the last week, +18.24% over the last month, and +94.51% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Monte Rosa Therapeutics, Inc. - Common Stock net income for the last quarter?
Monte Rosa Therapeutics, Inc. - Common Stock reported net income of -44.5 M for the last quarter. The previous quarter showed -46.13 M, which means net income changed by +3.54%.
How many employees does Monte Rosa Therapeutics, Inc. - Common Stock have?
As of the latest available data, Monte Rosa Therapeutics, Inc. - Common Stock has 161 employees. Workforce size can provide additional context about the company's scale and operations.
What is Monte Rosa Therapeutics, Inc. - Common Stock EBITDA?
Monte Rosa Therapeutics, Inc. - Common Stock EBITDA is -47.36 M, and its EBITDA margin is -1 124.99%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Monte Rosa Therapeutics, Inc. - Common Stock stock?
You can buy Monte Rosa Therapeutics, Inc. - Common Stock (GLUE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Monte Rosa Therapeutics, Inc. - Common Stock stock?
Investing in Monte Rosa Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GLUE chart and related analysis on metatrader.com as part of your research.